✦ LIBER ✦

Analysis of Ki-67 expression with neoadjuvant anastrozole or tamoxifen in patients receiving goserelin for premenopausal breast cancer

✍ Scribed by Hiroji Iwata; Norikazu Masuda; Yasuaki Sagara; Takayuki Kinoshita; Seigo Nakamura; Yasuhiro Yanagita; Reiki Nishimura; Hirotaka Iwase; Shunji Kamigaki; Hiroyuki Takei; Hitoshi Tsuda; Nobuya Hayashi; Shinzaburo Noguchi

Book ID: 115554737
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 453 KB
Volume: 119
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.27818

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant anastrozole versus tamoxifen

Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial

✍ Norikazu Masuda; Yasuaki Sagara; Takayuki Kinoshita; Hiroji Iwata; Seigo Nakamur 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 152 KB

Zoledronic acid prevents bone mineral de

Zoledronic acid prevents bone mineral density loss in premenopausal women receiving adjuvant treatment for hormone receptor-positive breast cancer: Preliminary results of a randomized, multicenter trial of zoledronic acid in patients receiving anastrozole or tamoxifen in combination with goserelin

✍ H. Hausmaninger 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 184 KB

Nonproliferative epithelial alteration a

Nonproliferative epithelial alteration and expression of estrogen receptor and Ki67 in the contralateral breast of women treated with tamoxifen for breast cancer

✍ José Fernando de Souza Sales Jr; César Cabello; Marcelo Alvarenga; Renato Zocchi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 223 KB

Continued use of goserelin to achieve ov

Continued use of goserelin to achieve ovarian function suppression in combination with a further aromatase inhibitor (exemestane) following prior treatment with anastrozole and/or tamoxifen in premenopausal women with oestrogen receptor positive advanced breast cancer

✍ A. Agrawal; Robertson; L. Winterbottom; K. Cheung 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 266 KB

Effects of cyclin D1gene amplification a

Effects of cyclin D1gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study

✍ Katja Lundgren, Matthew Brown, Silvia Pineda, Jack Cuzick, Janine Salter, Lila Z 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 747 KB

A prognostic model based on combining es

A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: Extension and analysis of a previously reported cohort of patients

✍ Miglietta, L.; Morabito, F.; Provinciali, N.; Canobbio, L.; Meszaros, P.; Naso, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 674 KB